News
A critical appraisal of PCSK9 inhibitors: PCSK9 monoclonal antibodies versus small interfering RNAEvolocumab prevents carotid artery wall thickening in paediatric HeFHPCSK9 plays critical role in abdominal aortic aneurysmPost hoc analysis: alirocumab benefits HeFH and T3HLP patientsResults from the German MILOS cohort demonstrate real-world effectiveness and safety of bempedoic acidPCSK9 inhibitors are unlikely to contribute to mood disorders
A critical appraisal of PCSK9 inhibitors: PCSK9 monoclonal antibodies versus small interfering RNAEvolocumab prevents carotid artery wall thickening in paediatric HeFHPCSK9 plays critical role in abdominal aortic aneurysmPost hoc analysis: alirocumab benefits HeFH and T3HLP patientsResults from the German MILOS cohort demonstrate real-world effectiveness and safety of bempedoic acidPCSK9 inhibitors are unlikely to contribute to mood disorders
